Axonics (AXNX)
(Delayed Data from NSDQ)
$66.86 USD
+0.06 (0.09%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $66.89 +0.03 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Axonics Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 366 | 274 | 180 | 112 | 14 |
Cost Of Goods | 92 | 76 | 65 | 44 | 6 |
Gross Profit | 275 | 198 | 116 | 67 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 301 | 263 | 188 | 121 | 88 |
Income After Depreciation & Amortization | -26 | -65 | -72 | -54 | -81 |
Non-Operating Income | 17 | 5 | 0 | -1 | 1 |
Interest Expense | -1 | 2 | 7 | 0 | 0 |
Pretax Income | -9 | -62 | -79 | -55 | -80 |
Income Taxes | -3 | -3 | 1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -6 | -60 | -80 | -55 | -80 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -6 | -60 | -80 | -55 | -80 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -53 | -58 | -51 | -79 |
Depreciation & Amortization (Cash Flow) | 12 | 12 | 14 | 3 | 2 |
Income After Depreciation & Amortization | -26 | -65 | -72 | -54 | -81 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 49.08 | 46.69 | 43.07 | 36.98 | 28.57 |
Diluted EPS Before Non-Recurring Items | -0.12 | -1.28 | -1.76 | -1.48 | -2.80 |
Diluted Net EPS (GAAP) | -0.12 | -1.28 | -1.86 | -1.48 | -2.80 |
Fiscal Year end for Axonics Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 91.41 | 109.74 | 93.10 | 92.89 | 70.65 |
Cost Of Goods | 22.16 | 26.97 | 24.00 | 22.70 | 18.15 |
Gross Profit | 69.25 | 82.76 | 69.10 | 70.19 | 52.50 |
SG&A, R&D, and Dept/Amort Expenses | 88.43 | 81.69 | 69.79 | 82.27 | 66.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | -19.18 | 1.07 | -0.69 | -12.08 | -14.37 |
Non-Operating Income | 3.97 | 4.54 | 4.27 | 4.25 | 3.63 |
Interest Expense | 0.06 | 0.15 | 0.08 | -0.17 | -0.68 |
Pretax Income | -15.27 | 5.46 | 3.50 | -7.65 | -10.06 |
Income Taxes | 3.85 | -1.12 | -0.43 | -0.30 | -0.81 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -19.11 | 6.57 | 3.93 | -7.34 | -9.25 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -19.11 | 6.57 | 3.93 | -7.34 | -9.25 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 50.93 | 50.94 | 50.09 | 49.09 | 48.58 |
Diluted EPS Before Non-Recurring Items | -0.38 | 0.13 | 0.08 | -0.15 | -0.19 |
Diluted Net EPS (GAAP) | -0.38 | 0.14 | 0.08 | -0.15 | -0.19 |